Literature DB >> 23968588

Intermittent hypoxia induces the proliferation of rat vascular smooth muscle cell with the increases in epidermal growth factor family and erbB2 receptor.

Yoji Kyotani1, Hiroyo Ota, Asako Itaya-Hironaka, Akiyo Yamauchi, Sumiyo Sakuramoto-Tsuchida, Jing Zhao, Kentaro Ozawa, Kosuke Nagayama, Satoyasu Ito, Shin Takasawa, Hiroshi Kimura, Masayuki Uno, Masanori Yoshizumi.   

Abstract

Obstructive sleep apnea is characterized by intermittent hypoxia (IH), and associated with cardiovascular diseases, such as stroke and heart failure. These cardiovascular diseases have a relation to atherosclerosis marked by the proliferation of vascular smooth muscle cells (VSMCs). In this study, we investigated the influence of IH on cultured rat aortic smooth muscle cell (RASMC). The proliferation of RASMC was significantly increased by IH without changing the level of apoptosis. In order to see what induces RASMC proliferation, we investigated the influence of normoxia (N)-, IH- and sustained hypoxia (SH)-treated cell conditioned media on RASMC proliferation. IH-treated cell conditioned medium significantly increased RASMC proliferation compared with N-treated cell conditioned medium, but SH-treated cell conditioned medium did not. We next investigated the epidermal growth factor (EGF) family as autocrine growth factors. Among the EGF family, we found significant increases in mRNAs for epiregulin (ER), amphiregulin (AR) and neuregulin-1 (NRG1) in IH-treated cells and mature ER in IH-treated cell conditioned medium. We next investigated the changes in erbB family receptors that are receptors for ER, AR and NRG1, and found that erbB2 receptor mRNA and protein expressions were increased by IH, but not by SH. Phosphorylation of erbB2 receptor at Tyr-1248 that mediates intracellular signaling for several physiological effects including cell proliferation was increased by IH, but not by SH. In addition, inhibitor for erbB2 receptor suppressed IH-induced cell proliferation. These results provide the first demonstration that IH induces VSMC proliferation, and suggest that EGF family, such as ER, AR and NRG1, and erbB2 receptor could be involved in the IH-induced VSMC proliferation.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  1-oxyl-2,2,6,6-tetramethyl-4-hydroxypiperidine; 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt; 4-(3-phenoxyphenyl)-5-cyano-2H-1,2,3-triazole; AGE; AR; CDK4; CPAP; ER; Epidermal growth factor; ErbB2 inhibitor II; HIF-1; IH; Intermittent hypoxia; NRG1; OSA; POD; PVDF; RASMC; ROS; SH; TBS-T; TEMPOL; VSMC; Vascular smooth muscle cell; WST-8; advanced glycation end product; amphiregulin; continuous positive airway pressure; cyclin-dependent kinase 4; epiregulin; erbB2 receptor; hypoxia inducible factor-1; intermittent hypoxia; neuregulin-1; obstructive sleep apnea; peroxidase; polyvinylidene difluoride; rat aortic smooth muscle cell; reactive oxygen species; sustained hypoxia; tris-buffered saline containing 0.1% Tween-20; vascular smooth muscle cell

Mesh:

Substances:

Year:  2013        PMID: 23968588     DOI: 10.1016/j.yexcr.2013.08.014

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  22 in total

1.  Neuregulin1β Effects on Brain Tissue via ERK5-Dependent MAPK Pathway in a Rat Model of Cerebral Ischemia-Reperfusion Injury.

Authors:  Ning Gu; Keli Ge; Cui Hao; Yaqing Ji; Hongyun Li; Yunliang Guo
Journal:  J Mol Neurosci       Date:  2017-03-06       Impact factor: 3.444

2.  B-cell lymphoma 2 rs17757541 C>G polymorphism was associated with an increased risk of coronary artery disease in a Chinese population.

Authors:  Yang Xuan; Li-Na Wang; Ping-Min Wei; Hong Zhi; Zu-Hong Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  A functional EGF+61 polymorphism is associated with severity of obstructive sleep apnea.

Authors:  Qunli Ding; Chao Cao; Zhongbo Chen; Mahebali Tabusi; Li Chen; Zaichun Deng
Journal:  Sleep Breath       Date:  2014-07-16       Impact factor: 2.816

Review 4.  Epiregulin: roles in normal physiology and cancer.

Authors:  David J Riese; Richard L Cullum
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

5.  Different impairment of immune and inflammation functions in short and long-term after ischemic stroke.

Authors:  Wen-Xing Li; Fei Qi; Jia-Qian Liu; Gong-Hua Li; Shao-Xing Dai; Tao Zhang; Fei Cheng; Dahai Liu; Song Guo Zheng
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

6.  Regulatory effects of AT₁R-TRAF6-MAPKs signaling on proliferation of intermittent hypoxia-induced human umbilical vein endothelial cells.

Authors:  Jin Shang; Xue-Ling Guo; Yan Deng; Xiao Yuan; Hui-Guo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31

7.  Impact of brief exercise on circulating monocyte gene and microRNA expression: implications for atherosclerotic vascular disease.

Authors:  Shlomit Radom-Aizik; Frank P Zaldivar; Fadia Haddad; Dan M Cooper
Journal:  Brain Behav Immun       Date:  2014-01-11       Impact factor: 7.217

8.  Human retinal pigment epithelial cell proliferation by the combined stimulation of hydroquinone and advanced glycation end-products via up-regulation of VEGF gene.

Authors:  Hiroki Tsujinaka; Asako Itaya-Hironaka; Akiyo Yamauchi; Sumiyo Sakuramoto-Tsuchida; Hiroyo Ota; Maiko Takeda; Takanori Fujimura; Shin Takasawa; Nahoko Ogata
Journal:  Biochem Biophys Rep       Date:  2015-05-29

9.  Role of hypoxia‑inducible factor‑1α in autophagic cell death in microglial cells induced by hypoxia.

Authors:  Xintao Wang; Jun Ma; Qiang Fu; Lei Zhu; Zhiling Zhang; Fan Zhang; Nan Lu; Aimin Chen
Journal:  Mol Med Rep       Date:  2017-03-01       Impact factor: 2.952

10.  Statins decrease vascular epithelial growth factor expression via down-regulation of receptor for advanced glycation end-products.

Authors:  Hiroki Tsujinaka; Asako Itaya-Hironaka; Akiyo Yamauchi; Sumiyo Sakuramoto-Tsuchida; Ryogo Shobatake; Mai Makino; Naonori Masuda; Hiromasa Hirai; Shin Takasawa; Nahoko Ogata
Journal:  Heliyon       Date:  2017-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.